• Neurana Pharmaceuticals Announces Publication in the Journal of Pain Research

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 23, 2020 /PRNewswire/ - Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the publication of results from the dose-ranging Phase 2 STAR Study of tolperisone in pat......
    Read more ...